See more : Iffe Futura, S.A. (NAT.MC) Income Statement Analysis – Financial Results
Complete financial analysis of Tilray Brands, Inc. (TLRY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tilray Brands, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- EnBio Holdings, Inc (6092.T) Income Statement Analysis – Financial Results
- Veji Holdings Ltd. (VEJIF) Income Statement Analysis – Financial Results
- PLBY Group, Inc. (PLBY) Income Statement Analysis – Financial Results
- Shanghai Shenda Co., Ltd (600626.SS) Income Statement Analysis – Financial Results
- First Guaranty Bancshares, Inc. (FGBI) Income Statement Analysis – Financial Results
Tilray Brands, Inc. (TLRY)
About Tilray Brands, Inc.
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 788.94M | 627.12M | 628.37M | 513.09M | 391.00M | 175.25M | 28.63M | 15.17M | 6.47M | 443.70K | 0.00 | 0.00 |
| Cost of Revenue | 565.59M | 480.16M | 511.56M | 389.90M | 253.31M | 119.50M | 3.97M | 2.33M | 1.88M | 567.59K | 0.00 | 0.00 |
| Gross Profit | 223.35M | 146.96M | 116.82M | 123.18M | 137.68M | 55.74M | 24.66M | 12.84M | 4.58M | -123.89K | 0.00 | 0.00 |
| Gross Profit Ratio | 28.31% | 23.43% | 18.59% | 24.01% | 35.21% | 31.81% | 86.13% | 84.63% | 70.87% | -27.92% | 0.00% | 0.00% |
| Research & Development | 635.00K | 682.00K | 1.52M | 830.00K | 1.85M | 1.03M | 380.00K | 365.52K | 168.99K | 55.95K | 0.00 | 0.00 |
| General & Administrative | 171.56M | 165.16M | 162.80M | 111.58M | 88.30M | 70.83M | 24.64M | 5.25M | 2.21M | 5.33M | 45.34K | 98.51K |
| Selling & Marketing | 79.17M | 65.78M | 65.86M | 44.12M | 29.92M | 20.67M | 9.21M | 4.95M | 2.76M | 579.52K | 0.00 | 0.00 |
| SG&A | 250.72M | 230.94M | 228.66M | 155.69M | 118.22M | 91.50M | 33.85M | 10.20M | 4.97M | 5.91M | 45.34K | 98.51K |
| Other Expenses | 146.74M | -66.91M | 115.19M | 35.22M | 15.68M | 10.41M | 1.98M | 379.96K | 277.37K | -3.28M | 0.00 | 0.00 |
| Operating Expenses | 398.10M | 325.11M | 345.37M | 191.74M | 135.75M | 102.94M | 37.32M | 11.28M | 5.42M | 6.01M | 45.34K | 98.51K |
| Cost & Expenses | 963.69M | 805.27M | 856.93M | 581.64M | 389.07M | 222.44M | 34.24M | 13.61M | 7.30M | 5.81M | 45.34K | 98.51K |
| Interest Income | 12.83M | 33.03M | 11.74M | 2.93M | 5.79M | 10.61M | 4.93M | 827.91K | 215.83K | 104.79K | 3.35K | 2.08K |
| Interest Expense | 49.26M | 13.59M | 39.68M | 30.90M | 24.78M | 5.75M | 1.05M | 287.34K | 215.83K | 104.79K | 3.35K | 2.08K |
| Depreciation & Amortization | 126.91M | 130.15M | 115.19M | 35.22M | 15.68M | 16.95M | 5.18M | 1.44M | 730.05K | 306.47K | 0.00 | 0.00 |
| EBITDA | -72.84M | -889.52M | -246.40M | -218.36M | -18.40M | -36.66M | -658.00K | 4.37M | 115.11K | -5.06M | -1.43M | -608.47K |
| EBITDA Ratio | -9.23% | -18.32% | 42.73% | 5.90% | 17.18% | 8.19% | -2.55% | 28.80% | -1.73% | -1,141.18% | 0.00% | 0.00% |
| Operating Income | -174.75M | -1.37B | 153.30M | -4.95M | 51.48M | -2.60M | -9.64M | -1.03M | -836.23K | -2.73M | -45.34K | -98.51K |
| Operating Income Ratio | -22.15% | -218.41% | 24.40% | -0.96% | 13.17% | -1.48% | -33.66% | -6.81% | -12.93% | -615.78% | 0.00% | 0.00% |
| Total Other Income/Expenses | -74.28M | -80.50M | 169.73M | -212.82M | -5.18M | 100.79M | 40.23M | 151.61K | 221.29K | -2.53M | 0.00 | 2.08K |
| Income Before Tax | -249.02M | -1.45B | -440.67M | -344.99M | -58.19M | -11.56M | 27.81M | 3.22M | -614.94K | -5.27M | -41.99K | -96.43K |
| Income Before Tax Ratio | -31.56% | -231.24% | -70.13% | -67.24% | -14.88% | -6.60% | 97.13% | 21.20% | -9.51% | -1,186.63% | 0.00% | 0.00% |
| Income Tax Expense | -26.62M | -7.18M | -6.54M | -8.97M | 2.82M | 631.19K | 4.97M | 99.29K | -920.06K | -3.38M | 0.00 | 0.00 |
| Net Income | -244.98M | -1.44B | -434.13M | -336.01M | -61.02M | -12.19M | 22.84M | 3.12M | 305.12K | -5.27M | -41.99K | -96.43K |
| Net Income Ratio | -31.05% | -230.10% | -69.09% | -65.49% | -15.61% | -6.96% | 79.77% | 20.54% | 4.72% | -1,186.63% | 0.00% | 0.00% |
| EPS | -0.33 | -2.34 | -0.90 | -1.25 | -0.61 | -0.06 | 0.17 | 0.04 | 0.01 | -0.14 | -0.01 | -0.04 |
| EPS Diluted | -0.33 | -2.34 | -0.90 | -1.25 | -0.61 | -0.06 | 0.16 | 0.04 | 0.01 | -0.14 | -0.01 | -0.04 |
| Weighted Avg Shares Out | 742.65M | 617.98M | 481.22M | 269.55M | 100.46M | 203.46M | 134.96M | 87.45M | 48.98M | 38.04M | 3.34M | 2.31M |
| Weighted Avg Shares Out (Dil) | 742.65M | 617.98M | 481.22M | 269.55M | 100.46M | 203.46M | 139.05M | 93.39M | 48.98M | 38.04M | 3.34M | 2.31M |
Prediction: Tilray Brands Won't Be a Cannabis Company in 5 Years
These 2 Marijuana Stocks Could Surge Under Trump's Second Term
The Top Canadian Cannabis Stocks for November 2024 Growth
Tilray Stock Hits 52-Week Low: A Buying Opportunity or a Warning Sign?
Green Stock News for November 14th, 2024: $SRFM $EH $TLRY $ADSE
Blue Point Brewery Expands Winter Seasonal Lineup with Blitz Beer American Lager and Hosts The Blue Point Blitz Celebration at Webster Hall
Charlotte's Web Reports 2024 Third quarter Financial Results
Get Ready for Winter with 10 Barrel's 13th Annual Pray for Snow Party
Tilray Brands stock analysis: very bad news for TLRY shares
Experience the Ultimate 420 Festival Celebration with SweetWater's 20th Anniversary Lineup Featuring The Revivalists, Marcus King Band, Greensky Bluegrass, Drive-By Truckers and Cypress Hill at Atlanta's Iconic Pullman Yards from April 18-20, 2025
Source: https://incomestatements.info
Category: Stock Reports